Biliary atresia is a serious liver condition in newborns where the bile ducts, the tiny tubes that carry bile from the liver to the intestine, become inflamed, scarred, and eventually blocked. Without functioning bile ducts, bile builds up inside the liver and progressively damages it. It affects roughly 1 in every 10,000 to 18,000 live births, making it the most common reason infants need liver transplants. The condition is not preventable, but early detection and surgery dramatically improve outcomes.
How Bile Duct Damage Progresses
In a healthy infant, bile flows from the liver through a network of ducts into the small intestine, where it helps digest fats and absorb nutrients. In biliary atresia, the immune system triggers inflammation that destroys the lining of these ducts. The body responds by producing scar tissue, which gradually replaces the ducts entirely.
This scarring doesn’t stop at the ducts. As bile backs up into the liver, specialized cells called stellate cells activate and begin laying down fibrous tissue throughout the organ. Left untreated, this fibrosis progresses to cirrhosis, where so much of the liver is replaced by scar tissue that it can no longer function. In most untreated infants, liver failure develops within the first two years of life.
What Causes It
No single cause has been identified. The leading theory is that genetically susceptible infants are born with slightly immature or abnormal bile ducts, and an external trigger pushes those ducts toward destruction. Researchers have identified several candidate genes, including ADD3, GPC1, and PKHD1, that may increase vulnerability. Key signaling pathways involved in bile duct development also show abnormal activity in affected infants.
Proposed triggers include viral infections, particularly cytomegalovirus (CMV), which the immature immune system of a newborn’s bile ducts may fail to recognize and clear effectively. CMV-associated biliary atresia tends to appear later, progress faster, and carry a worse prognosis. Environmental toxins that disrupt the delicate balance of protective compounds in fetal cells are another suspected contributor. In reality, it likely takes a combination of genetic predisposition and an environmental insult to set the disease in motion.
Two Main Forms
About 90% of cases are the isolated, or perinatal, form. These infants appear completely normal at birth aside from the bile duct problem. They typically develop symptoms in the first few weeks of life and initially maintain normal growth and development.
The remaining roughly 10% of cases in European and North American populations belong to the biliary atresia splenic malformation (BASM) syndrome. These infants have additional anatomical differences: the spleen may be absent or duplicated, internal organs may be reversed (situs inversus), the major vein returning blood from the lower body may be absent, or blood vessels near the liver may follow unusual routes. BASM is far less common in Asian populations, appearing in fewer than 3% of cases in India, China, and Japan, for reasons that remain unclear.
Signs Parents Notice First
The hallmark symptoms are jaundice that persists beyond two weeks of age, pale or clay-colored stools, and dark urine. Many healthy newborns have mild jaundice in their first week, so the critical distinction is jaundice that doesn’t resolve. Pale stools are particularly telling. Bile gives stool its normal brown or green color, so when bile can’t reach the intestine, stools turn grey, cream, white, or a light caramel color.
Several countries use stool color cards, first introduced in Japan in 1987 and Taiwan in 2002, that show parents a range of normal and abnormal stool colors to compare against their baby’s diapers. These cards have meaningfully improved early detection rates. A simple blood test measuring direct (conjugated) bilirubin can also flag the problem. A level of 0.6 mg/dL or higher in a newborn has shown 100% sensitivity for identifying cholestatic liver disease, which includes biliary atresia.
How It Is Diagnosed
When biliary atresia is suspected, doctors use a combination of blood tests, ultrasound, and liver biopsy to narrow down the diagnosis. On ultrasound, the gallbladder may appear shrunken or absent, and the bile ducts may not be visible. But the most informative test before surgery is a liver biopsy. Pathologists look for three key features: proliferation of tiny bile ductules (the liver’s attempt to create new drainage pathways), bile plugs trapped within the tissue, and bile pigments accumulating inside liver cells. The presence of these features strongly points toward biliary atresia rather than other causes of newborn jaundice.
The definitive diagnosis comes during surgery, when the surgeon can directly see the blocked or absent bile ducts and confirm the obstruction.
The Kasai Procedure
The primary surgery for biliary atresia is the Kasai portoenterostomy, named after the Japanese surgeon who developed it. The surgeon removes the scarred, nonfunctional bile duct remnant from the area where it connects to the liver. Then a loop of the baby’s small intestine is brought up and stitched directly to the exposed surface of the liver at that connection point. The goal is to create a new pathway so that bile can drain from the microscopic ducts still open within the liver directly into the intestine.
Timing is critical. The procedure works best when performed before 60 days of age. About half of babies who have the surgery before two months old achieve enough bile flow to grow and stay healthy for years. The longer the delay, the more liver damage accumulates and the lower the chances of restoring adequate drainage. This is why early recognition of persistent jaundice and pale stools matters so much.
Complications After Surgery
Even after a successful Kasai procedure, cholangitis (infection of the bile drainage system) is the most common complication. Because the intestine is now connected directly to the liver, bacteria can travel upward into the biliary system. Warning signs include fever or chills, a return of pale stools, worsening jaundice, and abdominal discomfort such as vomiting, poor feeding, or unusual irritability.
Cholangitis episodes require prompt treatment with intravenous antibiotics, typically for 10 to 14 days in suspected cases and 14 to 21 days when the infection is confirmed. Repeated episodes can cause additional liver scarring, so parents are usually taught to watch for these signs carefully in the months and years following surgery.
Nutritional Challenges
Even with improved bile flow after surgery, many infants with biliary atresia struggle to absorb fats and fat-soluble vitamins (A, D, E, and K). Bile is essential for breaking down dietary fat, and reduced bile flow means these nutrients pass through the intestine without being absorbed. This can lead to poor weight gain, weakened bones, bleeding problems, and neurological issues if left unaddressed.
Supplementation strategies often involve higher-than-normal doses of these vitamins, sometimes in water-soluble forms that don’t depend on bile for absorption. Vitamin E, for example, may be given in a special water-soluble formulation. Vitamin D might be provided as its active form, which bypasses the liver processing step. Vitamin K supplementation is guided by how well the blood clots. These infants typically need specialized formulas with fats that are easier to absorb without bile, and their nutritional status requires regular monitoring through blood tests.
When a Liver Transplant Is Needed
The Kasai procedure is not a cure. It buys time, but the majority of children with biliary atresia will eventually need a liver transplant. Some need one within the first two years because the Kasai surgery didn’t restore adequate bile flow. Others do well for years or even into adolescence before progressive fibrosis catches up.
The good news is that transplant outcomes for biliary atresia are excellent. In a study following 145 children over more than 20 years, patient survival was 95.8%, with a median follow-up of over 12 years. The transplanted livers themselves survived in 91% of cases over the same period. Many of these children grow up to lead largely normal lives, though they require lifelong medication to prevent organ rejection.
Living-donor transplants, where a parent or other adult donates a portion of their liver, have expanded the options for these small patients. Because a child needs only a small piece of liver, and the liver regenerates, both the donor and recipient can recover fully.